In summary, the COIN analysis results indicated that DSCR9 was highly correlated with several oncogenes and therefore it was very likely that its regulatory function could be employed to explain the reduced cancer incidence in patients with DS. This evidence concerns the gene DSCR9 and Dravet syndrome.